These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10693159)
1. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. Liu SK; Chen WJ; Chang CJ; Lin HN Neuropsychopharmacology; 2000 Mar; 22(3):311-9. PubMed ID: 10693159 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. Rémillard S; Pourcher E; Cohen H J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537 [TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
4. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Lee SM; Chou YH; Li MH; Wan FJ; Yen MH Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386 [TBL] [Abstract][Full Text] [Related]
5. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol]. López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849 [TBL] [Abstract][Full Text] [Related]
6. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890 [TBL] [Abstract][Full Text] [Related]
7. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
8. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol. Addington J; Addington D Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073 [No Abstract] [Full Text] [Related]
9. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428 [TBL] [Abstract][Full Text] [Related]
10. Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes. Marder SR; Glynn SM; Wirshing WC; Wirshing DA; Ross D; Widmark C; Mintz J; Liberman RP; Blair KE Am J Psychiatry; 2003 Aug; 160(8):1405-12. PubMed ID: 12900301 [TBL] [Abstract][Full Text] [Related]
11. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. Csernansky JG; Mahmoud R; Brenner R; N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998 [TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Cesková E; Svestka J Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306 [TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628 [TBL] [Abstract][Full Text] [Related]
15. Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial. Min SK; Rhee CS; Kim CE; Kang DY Yonsei Med J; 1993 Jun; 34(2):179-90. PubMed ID: 7691017 [TBL] [Abstract][Full Text] [Related]
16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
17. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. Zhang XY; Zhou DF; Shen YC; Zhang PY; Zhang WF; Liang J; Chen DC; Xiu MH; Kosten TA; Kosten TR Neuropharmacology; 2012 Apr; 62(5-6):1928-34. PubMed ID: 22227558 [TBL] [Abstract][Full Text] [Related]
18. Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia. Liberman RP; Gutkind D; Mintz J; Green M; Marshall BD; Robertson MJ; Hayden J Compr Psychiatry; 2002; 43(6):469-73. PubMed ID: 12439835 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related]
20. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients. Lee SM; Chou YH; Li MH; Wan FJ; Yen MH J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]